Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|September 14, 2023
Augmented antitumor effects of erlotinib and cabozantinib on A549 non-small cell lung cancer: In vitro and in vivo studiesKhalid Alhazzani, Meshal Alsahli, Ahmed Z Alanazi, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|February 11, 2022
Sorafenib, rapamycin, and venetoclax attenuate doxorubicin-induced senescence and promote apoptosis in HCT116 cellsHomood M As Sobeai, Munirah Alohaydib, Ali R Alhoshani, et al.
Cells|May 12, 2018
MDM2 Overexpression Modulates the Angiogenesis-Related Gene Expression Profile of Prostate Cancer CellsThiagarajan Venkatesan, Ali Alaseem, Aiyavu Chinnaiyan, et al.
Drug and Alcohol Dependence|July 12, 2020
Serum proteomic profiling of patients with amphetamine use disorderFawaz Alasmari, Sary Alsanea, Afshan Masood, et al.
Chemistry and Physics of Lipids|October 23, 2020
Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell linesMohammed Muqtader Ahmed, Farhat Fatima, Md Khalid Anwer, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|August 26, 2025
Talazoparib and radiation enhance the senolytic efficacy of venetoclax in therapy-induced senescent triple-negative breast cancer cellsSultan Almudimeegh, Mashal M Almutairi, Abrar Softah, et al.
Pageof 8